Capecitabine vs 5‐FU‐containing regimens
Time to progression · people with advanced gastric cancer
It is very uncertain whether capecitabine changes time to progression compared with 5‐FU‐containing regimens (very low certainty).
1 finding from 1 review
- HR 0.72 [0.47, 1.12]1 study · 85 participantsVery low